Nektar's #opioid painkiller gets a unanimous "no" vote from FDA adivsory panel, despite features of the drug intended to reduce the risk of addiction. Bulk of panel wants $NKTR to do more tests, provide more datahttps://xconomy.com/national/2020/01/14/fda-panel-votes-down-nektar-opioid-painkiller-asks-for-more-data/ …
Nektar won't do those tests and it's not waiting to see what the FDA says. Hours after the panel vote, the company announced it will withdraw its application and stop investment in the #opioid drug, #oxycodegol. $NKTR announcement here:https://www.prnewswire.com/news-releases/nektar-issues-statement-regarding-fda-advisory-committee-vote-for-oxycodegol-300987219.html …